- Release Date: 28/06/22 09:07
- Summary: Zantrene shows synergy with kinase inhibitors in melanoma
- Price Sensitive: Yes
- Download Document 1.79MB
Ann: Zantrene shows synergy with kinase inhibitors in melanoma
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.025(1.74%) |
Mkt cap ! $241.2M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.48 | $1.41 | $35.37K | 24.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3706 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 308 | 1 |
View Market Depth
| Last trade - 13.55pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.47 |
Change
0.025 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| $1.41 | $1.48 | $1.41 | 7483 | ||
| Last updated 14.09pm 31/05/2024 ? | |||||
| RAC (ASX) Chart |